explore -WSS

explore

author：fashion 2025-10-01 00:48:53 - browse：748

An army of wooden figures under blue and pink lighting — biotech coverage from STAT — Adobe

Biotech startup ReNAgade Therapeutics is cutting staff just seven months after raising the largest Series A round in the industry this year.

ReNAgade launched in May with hopes of becoming a one-stop shop for medicines targeting RNA, the genetic blueprints that cells use to make proteins instrumental in numerous diseases. These types of medicines are in high demand following the advent of mRNA vaccines for Covid and RNA-silencing therapies made by companies like Alnylam Pharmaceuticals.

ReNAgade was able to capitalize on that excitement when it raised a $300 million Series A round led by MPM Capital’s BioImpact Capital and F2 Ventures. But in recent days, the company decided to lay off around 10% of its 100-person team, according to a company statement and former employees’ posts on social media.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Doctors push to include dialysis machines in emergency stockpile

hotspot

WSS

Democrats are overperforming in 2023's special elections. Is it a clue for Biden vs. Trump?

Vatican is moving ahead with plan to reunite Ukrainian children taken to Russia with their families

Body of missing toddler recovered in Delaware River days after flood: Police

Southern California school board OKs curriculum after Gov. Gavin Newsom threatened a $1.5M fine

Slovenia has suffered its worst

Paxlovid rebound happens. Why and to whom are still a mystery

hotspot

explore

Wikipedia

BioMarin wins approval for gene therapy to treat hemophilia A

Caitlin Bernard's story shows physicians can't shy from advocacy

New air purifier tech could be key to improving indoor air quality

How artificial intelligence is being used to detect, treat cancer

How to save PrEP access — and even expand it

Review: 'Barbie' will hit you like a shot in the heart

DIEP, the 'gold standard' of breast reconstruction, is under threat

How CRISPR works, explained in two minutes

Tori Bowie and the unacceptable rates of Black maternal death

It was time to plan for my old age. If only I could stop crying

hotspot

Paxlovid rebound happens. Why and to whom are still a mystery

Review: 'Barbie' will hit you like a shot in the heart

Death toll from an explosion and collapse of a Paris building in June climbs to 3

Russia promises retaliation after Ukrainian drones hit a Russian tanker in 2nd sea attack in a day

How artificial intelligence is being used to detect, treat cancer

It was time to plan for my old age. If only I could stop crying

focus

hotspot

focus

knowledge